Answers are grounded in this paper and cite their sources.
Multicentre study determines viral infection prevalence in transfused sickle cell children, indicating safety needs.
Objective: the objective of the study is to determine the seroprevalence of transfusion-transmissible viral infections (TTVI) and identify associated factors. Material and Methods: This was a multicentre cross-sectional study conducted over 12 months in children aged 1-17 years with sickle cell disease who had been receiving transfusions for at least 3 months. Blood samples were analysed by membrane immunochromatography for virological markers and using the Cobas® e411 analyser when HIV-1/2 antibodies were detected. The variables studied were sociodemographic, anamnestic, clinical and biological. Statistical analysis was performed using Stata MP 16 software with a significance threshold set at 5%. Results: The seroprevalence of TTVI was 8.5% in children aged 8.9 ± 0.6 years on average; the sex ratio equal to 0.9. The disease was discovered at an average age of 2.4 ± 0.1 years following severe anaemia in 32.6% of cases. All children received red blood cell concentrates, with an average of 3.2 ± 0.2 bags. The viral markers found were anti- hepatitis C virus antibodies (3.7%), anti-HIV ½ antibodies (2.1%) and anti-Cytomegolovirus-H immunoglobulin M antibodies (2.1%). These infections occur more frequently in children with sickle cell disease who have an altered clinical condition and low haemoglobin levels. Conclusion: The high prevalence of viral infections amongst transfused children with sickle cell disease requires that transfusion safety measures be strengthened.
No takes yet. Share an insight, caveat, or question.
Kambourou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: